PeerView @PeerView Twitter profile

Last Seen Profiles

@jDrew103

@layton_duncan

@_BlaineWilliams

@j0rge74

@IanWatsonLab

@lex0623official

@MoveBuilders

@funalyt

@Prashaun_Snap

@RandyrouSeptian

@_saysorry1105

@lporaang

@DanielSilvb

@stw_pdg

@BettysAromas

@elisaagds

@jenhoganjourno

@shagbark_hick

@island574

@revoptom

@DavidVitiJr

@MarcGoldwein

@KippaTheFox

@Reese4Oblivion

@BlvkKing

@al_bb88

@t_2se

@adnkingdon

@JMurda_Ftw

@JLRees

@HAOSHIH324

@real_or_random

@MeganStifel

@lanita_moon

@wstrzelecki

PeerView

@PeerView

9 months

Newly posted! Check out our practice aids on #AML from our recently released activity from #SOHO2023 . Featuring @Daver_Leukemia & Gail J. Roboz, MD #MedEd #MedTwitter

0

7

38

PeerView

@PeerView

8 months

Watch Steven Brem, MD, Manmeet S. Ahluwalia, MD, MBA, FASCO, and Michelle Kim, MD, discuss #Glioblastoma updates from #SNO2023 - to participate, visit:

Shattering the Barriers to Glioblastoma Care: Revolutionary Advances With Innovative Technologies...

See a new #glioblastoma activity via @PeerView @StevenBremMD @BRAINTUMORDOC @MichelleMKimMD #SNO2023 #MedEd

lrn.peerview.com

0

19

35

PeerView

@PeerView

8 months

Get the latest evidence for #AntibodyDrugConjugates in #SolidTumors from an expert panel: #MedTwitter #MedEd #OncTwitter #Oncology #ESMO23 #WCLC23 @PTarantinoMD @erikahamilton9 @APassaroMD @YJanjigianMD

0

9

33

PeerView

@PeerView

2 years

Drs. Choueiri ( @DrChoueiri ), Pal ( @montypal ), and Zhang ( @TiansterZhang ) discuss novel therapies for advanced #RCC , including TKIs, immune checkpoint inhibitors, and combinations in this #CME activity based on an event at #ASCO22 and produced with @kcCURE

0

14

33

PeerView

@PeerView

1 year

Better navigate the new evidence and incorporate perioperative #Immunotherapy in modern management of #NSCLC , including neoadjuvant and adjuvant approaches, by watching @DoctorJSpicer & @AltorkiNasser in this new #MedEd video from #STS2023 #LungCancer

0

12

29

PeerView

@PeerView

6 years

Dr. Omid Hamid ( @OmidHamidMD ) explores new #cancer #immunotherapy targets and combinations under investigation at #PeerView #AACR18 symposium

0

17

31

PeerView

@PeerView

6 years

Prof. Solange Peters ( @peters_solange ) explains how to test for TMB at #PeerView #AACR18 #immunooncology symposium

0

25

29

PeerView

@PeerView

1 year

What are the pros/cons of neoadjuvant, adjuvant, or combined strategies of perioperative #Immunotherapy in #NSCLC ? Find out from @DoctorJSpicer , @sara_najmeh , and @paugalde20 in this educational activity from #AATS2023

Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immunotherapy, Individua...

See a new #NSCLC activity via @PeerView @DoctorJSpicer @sara_najmeh @paugalde20 #AATS2023 #LungCancer #MedEd

learn2.peerview.com

0

11

31

PeerView

@PeerView

6 months

Register ASAP for this January 18th #BiliaryCancer #MedEd Symposium at 5:15 PM PST during #GI24 ! With Drs. Milind Javle ( @JavleMilind ), Tanios Bekaii-Saab ( @GIcancerdoc ) & Rachna Shroff ( @rachnatshroff ) & developed with @curecc ! #Oncology #MedTwitter

0

19

28

PeerView

@PeerView

7 years

Dr. Harry Erba opening with a groundbreaking year for new approvals in #AML #ASH17 #PeerView

1

23

27

PeerView

@PeerView

3 years

If you are involved in #LungCancer care, you will want to watch our newest CME/MOC/CC/NCPD video. Hear from the experts, led by Stephen V. Liu, MD ( @StephenVLiu ) who discuss the biomarker testing and targeted therapies in NSCLC. #LCSM @LUNGevity

1

13

27

PeerView

@PeerView

7 months

PeerView was proud to share the impressive results of collaborative educational initiatives with @CllSociety at #ASH23 Sunday! These initiatives led to significant improvements in healthcare professionals' knowledge, skills, and intentions regarding #CLL patient care #MedEd

0

19

27

PeerView

@PeerView

7 months

Learn how #AntibodyDrugConjugates are improving patient outcomes in cancer care in a new expert-led #MedEd acttivty: #MedTwitter #MedEd #OncTwitter #Oncology #ESMO23 #WCLC23 @PTarantinoMD @erikahamilton9 @APassaroMD @YJanjigianMD

0

9

26

PeerView

@PeerView

2 years

Drs. Aleix Prat, Shanu Modi, and Paolo Tarantino explore the rationale for and data supporting the use of HER2-targeted therapies in HER2-low #BreastCancer in this new #MedEd activity. @prat_aleix @PTarantinoMD #MedTwitter

Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportun...

See a new #breastcancer activity via @PeerView @prat_aleix #MedEd

learn2.peerview.com

0

11

26

PeerView

@PeerView

2 years

Meet Prof Prat ( @prat_aleix ), Dr. Tarantino ( @PTarantinoMD ), and Dr. Modi live, in Paris on September 9th at 10:15 CEST for a #BreastCancer symposium during #ESMO22 . #BCSM #HER2low #MedEd

0

12

25

PeerView

@PeerView

6 years

Prof. Thomas Powles ( @powles_tom ) discussing the role of PD-L1 expression as a #biomarker for #cancer #immunotherapies at #PeerView #AACR18 symposium

0

17

24

PeerView

@PeerView

3 years

Watch leading #lungcancer experts Drs. Liu ( @StephenVLiu ), Aggarwal ( @CharuAggarwalMD ), Higgins ( @KHigginsMD ), and Stiles ( @BrendonStilesMD ) discuss multidisciplinary management of stage III #NSCLC & the practical nuances of using #immunotherapy . #MedEd

0

11

26

PeerView

@PeerView

2 years

Don't miss out on our recently released #LungCancer Practice Aids from #NACLC22 . Featuring #NSCLC experts @marinagarassino , @HosseinBorghaei , & @StephenVLiu Download here: #IASLC #MedEd #ADCs #IASLC

Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and Practical Considera...

See a new #NSCLC activity via @PeerView @marinagarassino @HosseinBorghaei @StephenVLiu #IASLC #NACLC22 #ADCs #MedEd

learn2.peerview.com

0

6

25

PeerView

@PeerView

1 year

Going to #GU23 ❓ Register for our new Clinical Consults #MedEd Event on #RenalCellCarcinoma that was produced with @kcCURE 🙌 2/16 in San Francisco, don't miss out 🎟 👀❗️ Featuring @montypal , @TiansterZhang , & Dr. McDermott: #RCC #MedTwitter 🙌

0

21

26

PeerView

@PeerView

1 year

Watch Drs. Schnitt ( @SchnittStuart ), Tarantino ( @PTarantinoMD ), and Reis-Filho demonstrate multidisciplinary collaboration to ensure appropriate #biomarker testing and treatment for patients with #HER2low #BreastCancer

A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer:...

See a new #breastcancer activity via @PeerView @SchnittStuart @PTarantinoMD #USCAP2023 #HER2low #MedEd

learn2.peerview.com

0

13

26

PeerView

@PeerView

2 months

Get practical guidance on using ADCs in individualized care of patients with #BladderCancer in an event featuring @PGrivasMDPhD , @TiansterZhang , & Evan Y. Yu, MD. Produced with our partner @BladderCancerUS . 6/1 at 6:30 PM CDT: #ASCO24 #MedEd

0

14

25

PeerView

@PeerView

6 months

Keep up with the evidence supporting the use of approved & emerging #HER2 targeted #BreastCancer therapies by watching Drs. Cortes, Hurvitz & Tarantino at in this new #MedEd video from #SABCS23 @GRASPtweets @LivingBeyondBC @JavierCortesMD @PTarantinoMD

1

12

25

PeerView

@PeerView

2 years

Watch #oncology experts discuss novel ADCs and how to incorporate them into individualized management plans for your patients with HER2-low #BreastCancer . Featuring @prat_aleix , Shanu Modi, MD, and @PTarantinoMD #MedEd

Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportun...

See a new #breastcancer activity via @PeerView @prat_aleix #MedEd

learn2.peerview.com

0

10

25

PeerView

@PeerView

6 months

Thank you, Tanios Bekaii-Saab, MD ( @GIcancerdoc ), Rachna Shroff, MD, MS, FASCO ( @rachnatshroff ), & Milind Javle, MD ( @JavleMilind ), our amazing faculty who delivered a fantastic #BiliaryCancer #MedEd ❗️ To view the replay please visit: #MedTwitter @curecc

0

14

24

PeerView

@PeerView

1 year

Hone your skills to integrate the latest therapeutics into tx plans using guidelines & principles of multidisciplinary/patient-centered care. A 🔜 2/16 #BladderCancer #MedEd Live Event❗️ With @BladderCancerUS 🙌 #GU23 @MattMilowsky @shilpaonc @AndreaNecchi

0

22

25

PeerView

@PeerView

5 months

Not all CDK4/6 inhibitors are the same! Examine the differences and current evidence for these agents in HR+, HER2- metastatic #breastcancer with Drs. Joyce O’Shaughnessy and @stolaney1 in a new #MedEd activity: #oncology

Custom Care Compass: Mastering Multifactorial Clinical Decision-Making in High-Risk HR+, HER2- MBC

See a new #metastaticbreastcancer activity via @PeerView @stolaney1 #MedEd

learn2.peerview.com

0

9

25

PeerView

@PeerView

2 years

The Therapeutic Advances in #BladderCancer Treatment: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care— led by @PGrivasMDPhD , @shilpaonc & @kalasri3 in SF on February 17 at 6:45 PM PST during #GU22 or virtually @BladderCancerUS

0

9

24

PeerView

@PeerView

9 months

Join #BreastCancer experts, @ErikaHamilton9 , @jhaveri_komal , @hoperugo , & @PTarantinoMD for a live @PeerView #MedEd symposium on 12/6 at 7:00 PM CST during #SABCS23 ! Produced with partners @GRASPtweets & @LivingBeyondBC : #HER2 #HER3 #TROP2 #MedTwitter

1

19

24

PeerView

@PeerView

5 years

Precision medicine in #PancreaticCancer ? Dr. @MPishvaian examines how the treatment landscape is evolving #PeerView #ASCO19 @letswinpc

0

9

24

PeerView

@PeerView

4 years

Join Alok A. Khorana MD, FACP, FASCO ( @aakonc ) and Jean M. Connors, MD ( @connors_md ) for a CME/MOC/CPE webcast on cancer-associated #VTE #ASCO20

0

19

24

PeerView

@PeerView

3 years

Our newest video features expert guidance on precision #NSCLC care with @StephenVLiu , Alexander Drilon, MD, D. Ross Camidge, MD, PhD, and @ZPiotrowskaMD . Watch today to hear the latest data from #ASCO21 and earn CME/MOC/CC/NCPD credit! @LUNGevity

1

15

22

PeerView

@PeerView

3 years

Drs. Shanu Modi and Sara Tolaney discuss current best practices in #HER2 positive #BreastCancer and share their perspectives on novel targeted therapies and combinations that may improve outcomes in challenging populations. #BCSM

1

12

22

PeerView

@PeerView

6 years

#PeerView #PKU symposium at #ACMGMtg18 underway. Barbara K. Burton, MD now discussing burden of this genetic disorder

1

16

22

PeerView

@PeerView

4 years

Hear Alok A. Khorana, MD, FACP, FASCO ( @aakonc ), and Jean M. Connors, MD ( @connors_md ) take on cancer-associated #VTE : Guidelines, therapeutic options, patient cases, and more! #CME #MedEd

0

10

23

PeerView

@PeerView

4 years

Registration open! Dr. Stiles ( @BrendonStilesMD ) leads a web broadcast on June 10th at 7 PM EDT - join the experts for the latest advances in #immunotherapy in earlier stages of #lungcancer #AATS2020

0

9

23

PeerView

@PeerView

5 years

Attend a #PeerView MasterClass, led by Nathan H. Fowler, MD ( @DrNathanFowler ), on #Bcell #lymphoma discussing novel targeted agents, next-gen antibodies, IMiDs, and CAR T cell therapy #ASCO19

0

15

21

PeerView

@PeerView

2 months

Join Drs. Pal ( @montypal ), Tannir, & Zhang ( @TiansterZhang ), on June 2 at 6:30 PM CDT in person or online during #ASCO24 for a #KidneyCancer #MedEd event. Produced with @KCCure . #Oncology #RenalCellCarcinoma #UrologicOncology

A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing

See a new #renalcellcarcinoma activity via @PeerView @Montypal @tiansterzhang #ASCO24 #MedEd

lrn.peerview.com

0

15

23

PeerView

@PeerView

9 months

Watch below for a message from Dr. David McDermott for Tonight's Symposium! Join the #RCC experts, @montypal , @AlbigesL , and David F. McDermott, MD, for a live educational event tonight, Friday, November 10, at 6:45 pm CST during #IKCSNA23 ! #MedEd

0

19

23

PeerView

@PeerView

6 years

Saturday's educational session for #AACR18 attendees: 1. TMB as the next #IO #biomarker 2. Operationalizing PD-L1, MSI/MMR, & TMB testing in practice 3. Emerging #immunotherapies & combinations (IDO, LAG-3, etc.) + other promising #biomarkers Register ➡

0

12

22

PeerView

@PeerView

2 years

HER2-targeted treatment advances in #HER2low #BreastCancer : An educational live event on September 9 at 10:15 CEST during #ESMO22 with Prof Prat ( @prat_aleix ), Dr. Tarantino ( @PTarantinoMD ), and Dr. Modi: #BCSM #HER2low #MedEd #MedTwitter

0

11

21

PeerView

@PeerView

1 year

Join the #ImmuneThrombocytopenia experts, David J. Kuter, MD, DPhil, & Cindy Neunert, MD, MSCS, in Chicago ⭐️TONIGHT⭐️, June 2nd 🗓 at 6:30 PM CDT at #ASCO23 for a “Clinical Consult” live #MedEd #ITP event that you won't want to miss❗️ #MedEd #MedTwitter

0

15

22

PeerView

@PeerView

2 years

Assess the potential of #TYK2 inhibitors to change the management of #SLE . Featuring expert Joan T. Merrill, MD: #Lupus #Rheumatology #MedEd

0

9

22

PeerView

@PeerView

2 years

Drs. Choueiri ( @DrChoueiri ), Pal ( @montypal ), and Zhang ( @TiansterZhang ) discuss novel therapies for advanced #RCC , including TKIs, immune checkpoint inhibitors, and combinations in this #CME activity based on an event at #ASCO22 and produced with @kcCURE

0

8

22

PeerView

@PeerView

1 year

Expand your #HCM treatment ❤️‍🩹 toolbox 🧰 to include novel therapies for personalizing management plans with @neallakdawala & @tikuowens at #ACC23 🔜 3/5 📆 at 6:15 AM CDT Live in New Orleans❗️🎟 🫀 #WCCardio #MedEd @ACCinTouch @Cardiology @worldheartfed

1

21

22

PeerView

@PeerView

1 year

Drs. Dominici ( @dr_laurad ), Tolaney ( @stolaney1 ), and Waks help you navigate complex decisions about local and systemic management of early #BreastCancer using illustrative cases in this new #MedEd video from #SSO2023 #MedTwitter

Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast...

See a new #breastcancer activity via @PeerView @dr_laurad @stolaney1 #SSO2023 #MedEd

learn2.peerview.com

0

11

22

PeerView

@PeerView

2 months

Candid Conversations on #UrothelialCancer : Join Dr. Shilpa Gupta, MD ( @shilpaonc ), and colleagues in person or online for a #BladderCancer #MedEd event during #ASCO24 on 5/31, at 7 PM CDT/8 PM EDT. @BladderCancerUS 🔗

0

16

20

PeerView

@PeerView

5 years

@DrAnasYounes and Dr. Steven Horwitz discuss important updates in peripheral T-cell #lymphoma management in this video CME activity titled, "Progress in Developing Novel Treatment Options for #PTCL ."

0

9

21

PeerView

@PeerView

3 years

Join Drs. Tolaney, Hamilton ( @ErikaHamilton9 ), & Kalinsky ( @KalinskyKevin ) for an engaging HR+ #BreastCancer virtual event developed with @tigerlilycares on 6/17 at 7 PM EDT and get the latest evidence and practical recommendations for care #ASCO21

0

9

21

PeerView

@PeerView

2 years

Learn to navigate the new evidence on perioperative #Immunotherapy , including neoadjuvant, adjuvant & combined approaches, with Drs. Altorki ( @AltorkiNasser ) & Spicer on 9/30 at 6:30 PM EDT during #ThoracicSummit2022 #LungCancer #NSCLC #AATS @AATSHQ

1

19

21

PeerView

@PeerView

5 years

How do you select a second-line treatment for a patient with advanced #HepatocellularCarcinoma ? Come hear Dr. Amit Singal’s considerations. #PeerView #ASCO19

0

11

21

PeerView

@PeerView

2 years

Examine the diagnostic criteria for #hypertrophiccardiomyopathy in a new CME/MOC activity featuring Professor Perry Elliott, @IacopoOlivotto and @SteveOmmen : #HCM #cardiology #MedEd

0

13

20

PeerView

@PeerView

6 months

Improve multidisciplinary coordination of patient-centered, team-based #BreastCancer care to help patient outcomes. Watch this video featuring @ErikaHamilton9 , @jhaveri_komal , @hoperugo , & @PTarantinoMD ! With @GRASPtweets & @LivingBeyondBC : #SABCS23 #MedEd

Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer: Risk...

See a new #breastcancer activity via @PeerView @erikahamilton9 @PTarantinoMD #SABCS2023 #MedEd

learn2.peerview.com

1

12

19

PeerView

@PeerView

6 months

Learn strategies from Matthew D. Galsky, MD ( @MattGalsky ), Shilpa Gupta, MD ( @shilpaonc ), & Andrea Necchi, MD ( @AndreaNecchi ) for incorporating novel therapies into clinical practice for patients with #BladderCancer . 1/26 at 6:45 PM PST: #GU24 #MedEd

0

15

21

PeerView

@PeerView

2 years

Join our #LungCancer expert, @BrendonStilesMD on September 30th at 12:15 PM EDT (also available virtually!) during #ThoracicSummit2022 for a #NSCLC #MedEd in-person and virtual symposium at 12:30 PM EST #AATS #EGFR #LCSM #MedEd #MedTwitter @AATSHQ

0

15

21

PeerView

@PeerView

2 months

Remember to join us on 5/31 at 6:30 PM CDT for a @PeerView #Lymphoma & #MultipleMyeloma live in-person & virtual symposium with Drs. Jagannath, @SabarishMD , & @JenCrombieMD . Please tweet your questions in advance! #ASCO24 #Bispecifics #MedEd

0

16

21

PeerView

@PeerView

1 year

Who's ready for tonight❓❗️🕢 See YOU 🫵 at Hyatt Regency Chicago in Grand Ballrooms CD & AB for our #ITP and #CLL programs❗️Plus MORE❗️Check out our full slate of symposia at #ASCO23 & join the one that is right for YOU: 👀 🙌

1

17

21

PeerView

@PeerView

2 years

Learn to implement best practices for effective collaboration among surgeons, #Oncologists , and the wider care team to determine the best multimodal intervention for each patient. 1/21 in San Diego during #STS2023 : #LungCancer #MedEd #NSCLC #Oncology

0

17

21

PeerView

@PeerView

2 months

Don't miss out on this #MedEd Seminars & Tumor Board on #GImalignancies on 5/31 at 6:30 PM CDT during #ASCO24 ! Featuring @YJanjigianMD , @DrShubhamPant , & John Strickler, MD, and produced with our partners @CureCC & @CCAlliance ! #GIcancers

Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to...

See a new #HER2 #GIcancer activity via @PeerView #ASCO24 #MedEd

lrn.peerview.com

0

15

20

PeerView

@PeerView

1 year

Going to #ASCO23 🛩❓ Our events begin TONIGHT at 6:30 PM CDT❗️ DON'T miss our 🌟14🌟 in-person & live virtual #Oncology #CME symposia on a plethora of topics❗️ Register NOW❗️ You won't want to miss this 🙌 See YOU there 👀❗️🎟 #MedEd #MedTwitter

1

20

PeerView

@PeerView

10 months

Why is early recognition and treatment of #CKD in patients with diabetes so important? Register NOW for a #Diabetes #MedEd Symposium during #EASD2023 featuring Prof. Dr. med Christoph Wanner and Hiddo J.L. Heerspink, PhD, PharmD. 10/2, at 11:00 AM CEST!

0

16

20

PeerView

@PeerView

11 months

Stay informed about the latest research, clinical trials, & available treatment options related to TROP2-targeting ADCs for #NSCLC by joining #LungCancer experts @StephenVLiu , @SunMinLim_ , & @delvysra in Singapore at #WCLC23 on 9/9 at 11:45 SGT! #MedEd

0

16

20

PeerView

@PeerView

3 years

Which patients with stage III #NSCLC should/should not receive #immunotherapy , when, and how? Stephen V. Liu, MD ( @StephenVLiu ) will lead a lively tumor board discussion during this live web broadcast on September 1 at 7:00 PM EDT. Join us! #LCSM

0

16

20

PeerView

@PeerView

7 months

Join #BiliaryCancer experts, Milind Javle, MD ( @JavleMilind ), Tanios Bekaii-Saab, MD ( @GIcancerdoc ), & Rachna Shroff, MD, MS, FASCO ( @rachnatshroff ) on 1/18 at 5:15 PM PST during #GI24 for a live #MedEd symposium! Produced with @curecc : #Oncology

0

16

20

PeerView

@PeerView

5 months

Improve your #NSCLC knowledge of the biology, structure, characteristics, & mechanisms of action of novel #ADCs by watching @benlevylungdoc host a competition featuring @marinagarassino , @StephenVLiu , & @ZPiotrowskaMD . 2/23 at 5:25 PM PST during #TTLC24 :

0

7

20

PeerView

@PeerView

2 years

Get expert recommendations for utilizing EGFR-targeted therapy in perioperative settings to improve outcomes in patients with #NSCLC , 1/22 at 12:40 PM PST during #STS2023 ! #Immunotherapy #Oncology #LungCancer #MedEd @jdoningtonmd @CatherineShuMD

0

17

20

PeerView

@PeerView

9 months

Watch a message below from #BreastCancer expert Drs Javier Cortes & @PTarantinoMD to join with Sara A. Hurvitz, at #SABCS23 for a live #MedEd @PeerView symposium! Developed with @GRASPtweets & @LivingBeyondBC ! Tuesday, December 5th at 7:00 PM CST:

0

16

20

PeerView

@PeerView

5 months

Learn team-based strategies to improve HR+, HER2- metastatic #breastcancer care in your clinic with Drs. Joyce O’Shaughnessy and @stolaney1 , as they discuss the role of CDK4/6 inhibitors in the first-line setting and beyond: #MedEd #oncology

Custom Care Compass: Mastering Multifactorial Clinical Decision-Making in High-Risk HR+, HER2- MBC

See a new #metastaticbreastcancer activity via @PeerView @stolaney1 #MedEd

learn2.peerview.com

0

16

20

PeerView

@PeerView

1 year

Although there are not yet any FDA-approved therapies for #NAFLD &/or #NASH , #Gastroenterology , & #Hepatology specialists have a lot of questions about treatment. What is out there? What is in development? This Tweetorial is endorsed by @AmerGastroAssn ! @DrLoomba @MedTweetorials

1

9

20

PeerView

@PeerView

2 years

Join @ErikaHamilton9 and colleagues for an engaging discussion of the exciting advances in advanced and early #BreastCancer during #SABCS22 on December 6 at 6:30 PM CST, produced in partnership with @GRASPtweets and @LivingBeyondBC #BCSM #MedEd

0

14

19

PeerView

@PeerView

1 year

Learn the power and promise of #ADCs : Improve your understanding of their composition, structure, & function. View #NSCLC experts @StephenVLiu , @MLJohnsonMD2 , @benlevylungdoc & @peters_solange in this new video from #ASCO23 produced with @LUNGevity : #MedEd

0

8

20

PeerView

@PeerView

2 months

Candid Conversations on #UrothelialCancer : Join Drs. Matthew D. Galsky ( @MattGalsky ), Andrea Necchi ( @AndreaNecchi ), and colleagues in person or online for a #BladderCancer #MedEd event during #ASCO24 on 5/31, at 7 PM CDT/8 PM EDT. @BladderCancerUS 🔗

0

11

17

PeerView

@PeerView

1 year

⭐️New in-person & virtual #Oncology CME symposia⭐️ Register today 🗓 to see our expert panelists discuss the newest data coming out of #ASCO23 ❗️ 🙌 #RCC #ITP #HNC #HCC #CLL #NSCLC #gyncsm #Melanoma #MultipleMyeloma #AML #SCLC #MDS #myelofibrosis #GICancers

0

18

19

PeerView

@PeerView

4 years

Attend an #immunotherapy #SCLC live web broadcast next Tuesday, 1/26 at 7 PM EST to hear Stephen V. Liu, MD ( @StephenVLiu ), Kristin Higgins, MD ( @KHigginsMD ), and other leading experts discuss the latest data and optimal multidisciplinary care #LCSM

0

15

18

PeerView

@PeerView

2 months

Get insights on the latest evidence supporting the further integration of BCL2i, FLT3i, IDHi, epigenetic strategies, and menin inhibitors in diverse #AML tx settings at 6:30 PM CDT. Produced with @HealthTree Foundation for AML #ASCO24 #HemOnc #PeerView

Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative...

See a new #acutemyeloidleukemia activity via @PeerView @EuniceWangMD #ASCO2024 #MedEd

lrn.peerview.com

0

12

18

PeerView

@PeerView

2 months

🚨 Join us during #ASCO24 🚨 Join Dr. John Strickler, MD, on 5/31, at 6:30 PM CDT for a Seminars & Tumor Board event with @CureCC & @CCAlliance . Explore #HER2 -targeting therapies for #GIcancers through real-life cases. 🔗 Register now:

0

15

19

PeerView

@PeerView

1 year

Register HERE: 🎟🙌 Catch the wave of innovation in #RCC ❗️ @PeerView and @KCCure for a Clinical Consults event featuring @montypal , @PBarataMD , @DrChoueiri , & @crisuarez08 on 6/2 🗓 at in-person in Chicago at 6:30 PM CDT (or online at 8:00 PM EDT)❗️

0

18

19

PeerView

@PeerView

1 year

Join Drs. Armstrong & Lebwohl tomorrow at 7:00 PM EST! This Live Virtual Symposium will inform you of new tx strategies involving #Psoriasis pathophysiology & disease severity, & give you a chance to chat live with the experts! #WCH23 #Dermatology

0

17

19

PeerView

@PeerView

2 years

Join @PeerView & @BladderCancerUS for an expert-led discussion on the clinical breakthroughs, individualized patient care, and innovative treatment options in #BladderCancer . Created for #AUA22 and featuring @UroDocAsh , @MattGalsky , & @JanetKukreja : #MedEd

2

9

18

PeerView

@PeerView

7 years

Join @DrChoueiri @montypal & @HHammersMD while they discuss first & second line treatment for advanced RCC tonight in Sandlake #GU17

0

10

18

PeerView

@PeerView

4 years

Get expert guidance in this new activity from Dr. Miguel-Angel Perales ( @DrMiguelPerales ) on current treatment options in acute and chronic, steroid-refractory #GVHD , and hear the latest evidence supporting the use of innovative therapies in this setting.

1

14

19

PeerView

@PeerView

7 months

Get the latest evidence for #AntibodyDrugConjugates in #SolidTumors from an expert panel: #MedTwitter #MedEd #OncTwitter #Oncology #ESMO23 #WCLC23 @PTarantinoMD @erikahamilton9 @APassaroMD @YJanjigianMD

0

7

19

PeerView

@PeerView

3 years

Join PeerView & @tigerlilycares on 6/10 at 7 PM EDT for a live web broadcast on #BreastCancer with Joyce O’Shaughnessy, MD, Rita Nanda, MD, & Priyanka Sharma, MD - Register here: #ASCO21 #TNBC

0

10

19

PeerView

@PeerView

1 year

Review the uses for and differences between amyloid PET, FDG PET, & tau PET to improve the diagnosis & disease course of #AlzheimersDisease , with Drs. Rabinovici & Nasrallah on 6/25 at 6:30 AM CDT during #SNMMI : #NuclearMedicine @SNM_MI @RabLab_UCSF

0

7

18

PeerView

@PeerView

2 months

Join #MultipleMyeloma experts, Robert Z. Orlowski, MD, PhD ( @Myeloma_Doc ); Noa Biran, MD ( @BiranNoa ); & Jonathan L. Kaufman, MD, on 6/01 at 6:30 PM CDT during #ASCO24 for a #MedEd event. Produced with @HealthTree Foundation for MM. #MedTwitter

Three Rs for Modern Myeloma Care: Delivering the Right Treatment for the Right Patient at the Right...

See a new #multiplemyeloma activity via @PeerView @JKaufmanMD @Myeloma_Doc #ASCO24 #MultipleMyeloma #MedEd

lrn.peerview.com

0

13

18

PeerView

@PeerView

1 year

Drs. Schnitt ( @SchnittStuart ), Tarantino ( @PTarantinoMD ), and Reis-Filho provide useful practical guidance for HER2 testing & results interpretation to identify patients with #HER2low #BreastCancer eligible for HER2-targeted therapies #USCAP2023 #MedEd

A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer:...

See a new #breastcancer activity via @PeerView @SchnittStuart @PTarantinoMD #USCAP2023 #HER2low #MedEd

learn2.peerview.com

0

5

19

PeerView

@PeerView

10 months

Analyze patient-provider videos to gain insight on shared decision-making to overcome barriers to #Obesity management with Drs. Donahoo & Sheer at a live #MedEd workshop on 10/12 at 4:30 PM EDT during #OW2023 : #MedTwitter

0

13

18

PeerView

@PeerView

10 months

Integrating New Technologies with TTFields for #SolidTumors —Hear the evidence on the efficacy & safety of this modality across approved & emerging indications. 10/1 at 6:30 PM PDT at #ASTRO23 . #PancreaticCancer @ErikSulman @hornezd @LealTiciana

1

12

18

PeerView

@PeerView

10 months

New in-person & virtual #Hematology CME/MOC/AAPA symposia on 12/8! Register today to watch our expert panelists discuss the newest data coming out of #ASH23 . Great #MedEd opportunities! #MedTwitter #MM #MDS #CLL #AML #COVID19

1

14

19

PeerView

@PeerView

2 months

Don’t miss our #CME meeting tonight at 6:30 PM CDT at the Hilton Chicago! Expert faculty and education‼️ See you 🫵 tonight! #ASCO24

0

15

19

PeerView

@PeerView

2 years

Register today for our #BreastCancer Live, in-person #MedEd Event during #ESMO22 in Paris! Featuring experts Professor Aleix Prat, MD, PhD, ( @prat_aleix ), Paolo Tarantino, MD, ( @PTarantinoMD ) and Shanu Modi, MD: #BCSM #HER2low

0

7

19

PeerView

@PeerView

4 years

Watch Drs. Arjun Balar ( @ArjunBalarMD ) & Petros Grivas ( @PGrivasMDPhD ) as these two experts explore novel strategies for treating patients with #BladderCancer in this new CME/MOC/CPE/CNE video.

0

8

19

PeerView

@PeerView

4 months

Sharpen your skills to conduct proper patient evaluations, risk assessment, and biomarker testing to inform treatment planning for patients with different subtypes of early #BreastCancer ( #EBC ). 3/21 at 7:00 PM EDT during #SSO2024 : @dr_laurad @jane_meisell

0

15

17

PeerView

@PeerView

1 year

Watch our video featuring Lincoln, an adolescent with #FOP , & his mother, Trish. Hear their experiences with diagnosis & management as well as insight on resources they have found helpful. Produced with @ifopa & @ASBMR : #IFOPA #FOPAwareness #CureFOP #MedEd

PeerView - Can YOU Avoid Iatrogenic Harm? Understanding and Identifying Fibrodysplasia Ossificans...

PeerView - New #FibrodysplasiaOssificansProgressiva series from @PeerView #CME #FOP

peerview.com

0

19

PeerView

@PeerView

2 years

Dr. Nasser Altorki ( @AltorkiNasser ), & Dr. Jonathan D. Spicer ( @DoctorJSpicer ) are presenting the latest #Immunotherapy data & case-based practicalities in stage I-III #LungCancer during #AATS2022 - incorporating ICIs into multimodal tx plans 5/14 #NSCLC

0

11

19

PeerView

@PeerView

5 years

New therapies in #mantlecelllymphoma : hear Dr. John Allan's review of the latest in this CME activity.

0

8

19

PeerView

@PeerView

2 years

Are you ready for the future of #RenalCellCarcinoma treatment? Get a roadmap for bringing novel targeted agents, immunotherapy, and combination strategies to your patients at our 2/17 dinner event at 6:45 PM PST #GU22 . @montypal @TiansterZhang @kcCURE

0

12

19

PeerView

@PeerView

9 months

Stay up to date on the latest practice-changing advancements in #Glioblastoma management with experts @StevenBremMD @BrainTumorDoc @MichelleMKimMD ! Join PeerView & @theABTA on Thursday, November 16th at 5:15 PM PST during #SNO2023 ! #BTSM #BrainTumor #MedEd

0

6

19

PeerView

@PeerView

8 months

Effectively collaborate with the multidisciplinary #BreastCancer care team to implement HER2 testing & select & sequence therapies. With @JavierCortesMD , @PTarantinoMD , & Dr. Sara A. Hurvitz. 12/5 at 7:00 PM CST: #SABCS23 @GRASPtweets @LivingBeyondBC

0

9

19

PeerView

@PeerView

8 months

Improve multidisciplinary coordination of patient-centered, team-based #BreastCancer care to improve patient outcomes. 12/6 at 7 PM CST with @ErikaHamilton9 , @jhaveri_komal , @hoperugo , & @PTarantinoMD ! With @GRASPtweets & @LivingBeyondBC : #SABCS23 #MedEd

0

6

19

PeerView

@PeerView

3 years

#Immunotherapy and targeted treatment advances in #BreastCancer : Join PeerView & @tigerlilycares for a web broadcast on June 10 at 7:00 PM EDT with Joyce O’Shaughnessy, MD, Rita Nanda, MD, & Priyanka Sharma, MD #ASCO21 #BCSM

0

10

19